Sage Journals: Discover world-class research

Free access

Review article

First published 2018-9

A New Perspective on the Nitrate–Phosphodiesterase Type 5 Inhibitor Interaction

Robert A. Kloner, Paul Goggin, Irwin Goldstein [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Review article

First published 2022-9

Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review

Farnoosh Farahbod, Parham Talebi-Boroujeni, Catherine MT Sherwin [...]

Journal of Endometriosis and Pelvic Pain Disorders

Free access

Research article

First published 2008-10

Phosphodiesterase Type-5 Inhibitor and Oxidative Stress

L. Speranza, S. Franceschelli, M. Pesce [...]

International Journal of Immunopathology and Pharmacology

Open access

Case report

First published 2014

Switching from Nitrate Therapy to Ranolazine in Patients with Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction

Dioma U. Udeoji, Ernst R. Schwarz

Clinical Medicine Insights: Case Reports

Retricted access

Research article

First published 2014-2

Impact of Phosphodiesterase Type 5 Inhibitor Treatment on the Rates of Sexually Transmitted Diseases in a Veterans Affairs Medical Center Patient Population

Jason M. Corbo, Jamie N. Brown, William E. Bryan [...]

Journal of Pharmacy Practice

Free access

Research article

First published 2018-3

Effects of phosphodiestrase type 5 inhibitors in epinephrine-induced arrhythmia in rats: Involvement of lactate dehydrogenase and creatine kinase downregulation and adiponectin expression

AAA Salama, RE Mostafa, EA Omara

Human & Experimental Toxicology

Free access

Review article

First published 2009-10

Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Antonio Aversa, Roberto Bruzziches, Davide Francomano [...]

Therapeutic Advances in Urology

Open access

Research article

First published 2017-11

Low-Intensity Extracorporeal Shockwave Therapy Can Improve Erectile Function in Patients Who Failed to Respond to Phosphodiesterase Type 5 Inhibitors

Chia-Chun Tsai, Chii-Jye Wang, Yung-Chin Lee [...]

American Journal of Men's Health

Retricted access

Research article

First published 2025-11

Daily phosphodiesterase type 5 inhibitors plus acetylsalicylic acid improve curvature progression and pain intensity during the active phase of peyronie’s disease

Lucio Dell’Atti, Viktoria Slyusar

Urologia Journal

Retricted access

Research article

First published 2013-2

Role of Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms

Mindi S Miller

Annals of Pharmacotherapy

Search results